Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging04:43

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

7.3K
This protocol describes the steps taken to induce KRAS lung tumors in mice as well as the quantification of formed tumors by ultrasound imaging. Small tumors are visualized in early timepoints as B-lines. At later timepoints, relative tumor volume measurements are achieved by the measurement tool in the ultrasound...
7.3K
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

7.5K
The use of an RNA-based approach to determine quantitative immune profiles of solid tumor tissues and leverage clinical cohorts for immune-oncology biomarker discovery is described through a molecular and informatics...
7.5K
Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

8.8K
This protocol describes the establishment of a tumor-bearing mouse model to monitor tumor progression and angiogenesis in real-time by dual bioluminescence...
8.8K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

10.3K
Here we describe a method to separate and enrich components of the tumor immune and non-immune microenvironment in established subcutaneous tumors. This technique allows for the separate analysis of tumor immune infiltrate and non-immune tumor fractions which can permit comprehensive characterization of the tumor immune...
10.3K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

12.5K
We describe a protocol for preclinical in vivo tracking of cancer metastasis. It is based on a radionuclide-fluorescence reporter combining the sodium iodide symporter, detected by non-invasive [18F]tetrafluoroborate-PET, and a fluorescent protein for streamlined ex vivo confirmation. The method is applicable for preclinical in vivo cell tracking beyond tumor...
12.5K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.

Journal of medical virology·2021
Same author

Complete mitochondrial genome of the spotted alfalfa aphid, <i>Therioaphis trifolii</i> (Hemipera: Aphididae).

Mitochondrial DNA. Part B, Resources·2020
Same author

The complete mitochondrial genome of the mealy plum aphid, <i>Hyalopterus pruni</i> (Hemiptera: Aphididae).

Mitochondrial DNA. Part B, Resources·2020
Same author

LncRNA PART1 promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-17-5p.

Journal of cellular biochemistry·2020
Same author

Anemoside B4 Protects against Acute Lung Injury by Attenuating Inflammation through Blocking NLRP3 Inflammasome Activation and TLR4 Dimerization.

Journal of immunology research·2020
Same author

Maternal Methyl-Donor Micronutrient Supplementation During Pregnancy Promotes Skeletal Muscle Differentiation and Maturity in Newborn and Weaning Pigs.

Frontiers in nutrition·2020

Related Experiment Video

Updated: Jan 20, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.5K

[Progress on interleukin-27 in tumor immunity].

Jia He1, Qing-qing Wang1

  • 1Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, China.

Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|June 4, 2015
PubMed
Summary

Interleukin-27 (IL-27) cytokine influences both innate and adaptive immunity, impacting tumor progression. Research reviews IL-27

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Interleukin-27 (IL-27) is a heterodimeric cytokine belonging to the IL-6/IL-12 family, linking innate and adaptive immunity.
  • Primarily produced by antigen-presenting cells, IL-27 targets various immune cells, including T cells, NK cells, macrophages, and dendritic cells.

Purpose of the Study:

  • To review current research on the multifaceted roles of IL-27 in the biological regulation of tumors.
  • To explore IL-27's dual impact on antitumor immunity and tumor progression.

Main Methods:

  • Literature review of existing studies on IL-27's function in cancer biology.
  • Analysis of IL-27's mechanisms in immune cell modulation and tumor development.

Main Results:

More Related Videos

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

8.8K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.3K

Related Experiment Videos

Last Updated: Jan 20, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.5K
Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

8.8K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.3K
  • IL-27 exhibits antitumor effects by promoting cytotoxic T cells, regulating T cell differentiation, enhancing NK cell activity, and inhibiting angiogenesis.
  • Conversely, IL-27 can also promote tumor progression and metastasis.
  • IL-27 shows potential as a diagnostic marker for tumors due to its association with tumor occurrence and development.

Conclusions:

  • IL-27 plays a complex and often contradictory role in tumor biology, acting as both an inhibitor and promoter.
  • Understanding IL-27's dual functions is crucial for developing novel cancer immunotherapies and diagnostic strategies.